<DOC>
	<DOCNO>NCT02794805</DOCNO>
	<brief_summary>An Octanoate breath test use ass presence Hepatocellular Carcinoma subject risk . The gold standard MRI .</brief_summary>
	<brief_title>Determination HCC With Octanoate Breath Test vs. MRI Diagnosis</brief_title>
	<detailed_description>1 . Informed consent obtain patient prior enrollment . 2 . The trial conduct compliance protocol , GCP standard , applicable regulatory requirement . 3 . This study cross-sectional , patient enrol walk basis . Once one arm complete one enrich order obtain least 50 positive least 50 negative HCC subject define MRI . 4 . All patient undergo AFP US result within past three month . 5 . If patient undergoes liver FNA , biopsy result evaluate presence HCC . 6 . For patient , case report form complete . 7 . All patient undergo physical examination , medical history/concomitant medication , weight , height age record . Furthermore , recent ( past 3 month ) blood test result , available , may record . 8 . If relevant ( woman child bear age ) , pregnancy test perform rule pregnancy perform breath test . 9 . All MRI negative patient low OBT result undergo additional MRI within 6 12 month post OBT rule HCC occurrence . 10 . If available , additional MRI/CT/US result record within patient 's CRF .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Any patient chronic liver disease risk HCC . 2 . Age ≥ 18 year . 3 . Patient MRI result ( positive negative HCC ) 3 month prior recruitment schedule MRI trial period . 4 . Patient naïve HCC treatment ( RFA TACE Oral HCC treatment ) since last MRI . 1 . Any patient chronic liver disease risk HCC . 2 . Age ≥ 18 year . 3 . Patient MRI result ( positive negative HCC ) 3 month prior recruitment schedule MRI trial period . 4 . Patient naïve HCC treatment ( RFA TACE Oral HCC treatment ) since last MRI . 5 . Patients currently receive total parenteral nutrition contraindication oral drug . 6 . Women pregnant breast feeding . 7 . Patient take drug interfere octanoate metabolism also cause NAFLD independent metabolic syndrome , include : corticosteroid , amiodarone , tetracycline , valproic acid , methotrexate , stavudine , zidovudine . 8 . Patient , base opinion investigator , enrol study . 9 . Patient unable unwilling sign inform consent . 10 . Patients participate clinical trial evaluate experimental treatment procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>